6t9o
From Proteopedia
(Difference between revisions)
												
			
			| m  (Protected "6t9o" [edit=sysop:move=sysop]) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==CryoEM structure of human polycystin-2/PKD2 in UDM supplemented with PI(3,5)P2== | |
| - | + | <StructureSection load='6t9o' size='340' side='right'caption='[[6t9o]], [[Resolution|resolution]] 3.39Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6t9o]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6T9O OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6T9O FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=UMQ:UNDECYL-MALTOSIDE'>UMQ</scene></td></tr> | |
| - | [[Category:  | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6t9o FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6t9o OCA], [http://pdbe.org/6t9o PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6t9o RCSB], [http://www.ebi.ac.uk/pdbsum/6t9o PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6t9o ProSAT]</span></td></tr> | 
| + | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/PKD2_HUMAN PKD2_HUMAN]] Defects in PKD2 are the cause of polycystic kidney disease 2 (PKD2) [MIM:[http://omim.org/entry/613095 613095]]. PKD2 is a disorder characterized by progressive formation and enlargement of cysts in both kidneys, typically leading to end-stage renal disease in adult life. Cysts also occurs in the liver and other organs. It represents approximately 15% of the cases of autosomal dominant polycystic kidney disease. PKD2 is clinically milder than PKD1 but it has a deleterious impact on overall life expectancy.<ref>PMID:9326320</ref> <ref>PMID:10541293</ref> <ref>PMID:10411676</ref> <ref>PMID:10835625</ref> <ref>PMID:11968093</ref> <ref>PMID:12707387</ref> <ref>PMID:14993477</ref> <ref>PMID:15772804</ref> <ref>PMID:21115670</ref>   | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/PKD2_HUMAN PKD2_HUMAN]] Involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (By similarity). PKD1 and PKD2 may function through a common signaling pathway that is necessary for normal tubulogenesis (By similarity). Acts as a regulator of cilium length, together with PKD1 (By similarity). The dynamic control of cilium length is essential in the regulation of mechanotransductive signaling. The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases flow-induced signaling (By similarity). Functions as a calcium permeable cation channel.  | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Arrowsmith, C H]] | ||
| + | [[Category: Baronina, A]] | ||
| + | [[Category: Bountra, C]] | ||
| + | [[Category: Carpenter, E P]] | ||
| + | [[Category: Edwards, A M]] | ||
| + | [[Category: Grieben, M]] | ||
| [[Category: Nasrallah, C]] | [[Category: Nasrallah, C]] | ||
| - | [[Category:  | + | [[Category: Pike, A C.W]] | 
| - | [[Category:  | + | [[Category: Structural genomic]] | 
| - | [[Category:  | + | [[Category: Shintre, C]] | 
| [[Category: Wang, Q]] | [[Category: Wang, Q]] | ||
| - | [[Category:  | + | [[Category: Ion channel]] | 
| - | [[Category:  | + | [[Category: Membrane protein]] | 
| - | [[Category:  | + | [[Category: Polycystic kidney disease]] | 
| - | [[Category:  | + | [[Category: Sgc]] | 
| - | [[Category:  | + | [[Category: Transient receptor potential channel]] | 
| - | + | ||
Revision as of 15:38, 20 November 2019
CryoEM structure of human polycystin-2/PKD2 in UDM supplemented with PI(3,5)P2
| 
 | |||||||||||
